CDK8-IN-6

Modify Date: 2024-08-10 11:08:07

CDK8-IN-6 structure	Common Name	CDK8-IN-6
	CAS Number	2415156-27-1	Molecular Weight	413.04
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₆H₃₇ClN₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of CDK8-IN-6

CDK8-IN-6 (compound 9) is a potent cyclin-dependent kinase 8 (CDK8) inhibitor with an Kd of 13 nM. CDK8-IN-6 shows cytotoxicity for MOLM-13, OCI-AML3, MV4-11, NRK and H9c2 cells with IC50s of 11.2, 7.5, 8.6, 20.5, 12.5-25 µM, respectively. CDK8-IN-6 has the potential for the research of AML-cancer[1].

Name	CDK8-IN-6

Description	CDK8-IN-6 (compound 9) is a potent cyclin-dependent kinase 8 (CDK8) inhibitor with an Kd of 13 nM. CDK8-IN-6 shows cytotoxicity for MOLM-13, OCI-AML3, MV4-11, NRK and H9c2 cells with IC50s of 11.2, 7.5, 8.6, 20.5, 12.5-25 µM, respectively. CDK8-IN-6 has the potential for the research of AML-cancer[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> CDK
Target	CDK8:13 nM (Kd)
References	[1]. Solum E, et al. New CDK8 inhibitors as potential anti-leukemic agents - Design, synthesis and biological evaluation. Bioorg Med Chem. 2020 May 15;28(10):115461.

Molecular Formula	C₂₆H₃₇ClN₂
Molecular Weight	413.04

CDK8-IN-6

Use of CDK8-IN-6

Names

CDK8-IN-6 Biological Activity

Chemical & Physical Properties